‘Remembrance work is future work’: Gilead commits $3M for HIV/AIDS education and preservation

Volunteers from the pharmaceutical company Gilead Sciences descended into the National AIDS Memorial Grove in San Francisco on Thursday afternoon to spruce up the green space and celebrate the announcement of a three-year commitment of $3 million for the memorial’s work.

The National AIDS Memorial and Gilead, a Foster City-based drugmaker, will direct $3 million over the course of three years to programming for HIV education, scholarships for individuals pursuing careers in public health, and the preservation of items tied to the HIV/AIDS epidemic.